Antipsychotics in the treatment of first-episode schizophrenia

Celia Feetam*, John Donoghue

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

In this article, the characteristics of onset, symptoms and outcome of first-episode schizophrenia are described. The guidance from the National Institute for Clinical Excellence, to consider atypical antipsychotics as first-line agents for the treatment of first-episode schizophrenia because of a reduced incidence of extrapyramidal symptoms with these agents, is discussed. The propensity for atypical antipsychotics to induce extrapyramidal symptoms is reviewed.
Original languageEnglish
Pages (from-to)405-408
Number of pages4
JournalPharmaceutical Journal
Volume270
Issue number7241
Publication statusPublished - 22 Mar 2003

Fingerprint Dive into the research topics of 'Antipsychotics in the treatment of first-episode schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Feetam, C., & Donoghue, J. (2003). Antipsychotics in the treatment of first-episode schizophrenia. Pharmaceutical Journal, 270(7241), 405-408.